The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease
Abstract
Object. The use of deep brain stimulation (DBS) of the subthalamic nucleus (STN) has been associated with a marked initial improvement in individuals with advanced Parkinson disease (PD). Few data are available on the long-term outcomes of this procedure, however, or whether the initial benefits are sustained over time. The authors present the long-term results of a cohort of 25 individuals who underwent bilateral DBS of the STN between 1996 and 2001 and were followed up for 1 year or longer after implantation of the stimulator. Methods. Patients were evaluated at baseline and repeatedly after surgery by using the Unified Parkinson's Disease Rating Scale (UPDRS); the scale was applied to patients during periods in which antiparkinsonian medications were effective and periods when their effects had worn off. Postoperative UPDRS total scores and subscores, dyskinesia scores, and drug dosages were compared with baseline values, and changes in the patients' postoperative scores were evaluated to assess the possibility that the effect of DBS diminished over time. In this cohort the median duration of follow-up review was 24 months (range 12–52 months). The combined (ADL and motor) total UPDRS score during the medication-off period improved after 1 year, decreasing by 42% relative to baseline (95% confidence interval [CI 35–50%], p < 0.001) and the motor score decreased by 48% (95% CI 42–55%, p < 0.001). These gains did diminish over time, although a sustained clinical benefit remained at the time of the last evaluation (41% improvement over baseline, 95% CI 31–50%; p < 0.001). Axial subscores at the time of the last evaluation showed only a trend toward improvement (p = 0.08), in contrast to scores for total tremor (p < 0.001), rigidity (p < 0.001), and bradykinesia (p = 0.003), for which highly significant differences from baseline were still present at the time of the last evaluation. Medication requirements diminished substantially, with total medication doses reduced by 38% (95% CI 27–48%, p < 0.001) at 1 year and 36% (95% CI 25–48%, p < 0.001) at the time of the last evaluation; this decrease may have accounted, at least in part, for the significant decrease of 46.4% (95% CI 20.2–72.5%, p = 0.007) in dyskinesia scores obtained by patients during the medication-on period. No preoperative demographic variable, such as the patient's age at the time of disease onset, age at surgery, sex, duration of disease before surgery, preoperative drug dosage, or preoperative severity of dyskinesia, was predictive of long-term outcome. The only predictor of a better outcome was the patient's preoperative response to levodopa. Conclusions. In this group of patients with advanced PD who underwent bilateral DBS of the STN, sustained improvement in motor function was present a mean of 2 years after the procedure, and sustained reductions in drug requirements were also achieved. Improvements in tremor, rigidity, and bradykinesia were more marked and better sustained over time than improvements in axial symptoms. A good preoperative response to levodopa predicted a good response to surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent Developments in Parkinson's Disease
Hurtig, H. I. (1987) · Neurology · doi:10.1212/wnl.37.5.893 · Cited by 1,920
Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D., & Benabid, A.-L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391603 · Cited by 1,853
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa000827 · Cited by 1,514
Core assessment program for intracerebral transplantations (CAPIT)
Langston, J. W., Widner, H., Goetz, C. G., Brooks, D., Fahn, S., Freeman, T., & Watts, R. (1992) · Movement Disorders · doi:10.1002/mds.870070103 · Cited by 1,008
Kumar, R., Lozano, A. M., Kim, Y. J., Hutchison, W. D., Sime, E., Halket, E., & Lang, A. E. (1998) · Neurology · doi:10.1212/wnl.51.3.850 · Cited by 634
Self-citationSaint-Cyr, J. A. (2000) · Brain · doi:10.1093/brain/123.10.2091 · Cited by 554
Self-citationHobson, D. E., Lang, A. E., Martin, W. R. W., Razmy, A., Rivest, J., & Fleming, J. (2002) · JAMA · doi:10.1001/jama.287.4.455 · Cited by 553
Self-citationMorrish, P. K., Rakshi, J. S., Bailey, D. L., Sawle, G. V., & Brooks, D. J. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.3.314 · Cited by 510
Behavioural disorders, Parkinson's disease and subthalamic stimulation
Houeto, J. L. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.701 · Cited by 500
Clinical predictive factors of subthalamic stimulation in Parkinson's disease
Welter, M. L., Houeto, J. L., Tezenas du Montcel, S., Mesnage, V., Bonnet, A. M., Pillon, B., Arnulf, I., Pidoux, B., Dormont, D., Cornu, P., et al. (2002) · Brain · doi:10.1093/brain/awf050 · Cited by 426
Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD
Volkmann, J., Allert, N., Voges, J., Weiss, P. H., Freund, H.-J., & Sturm, V. (2001) · Neurology · doi:10.1212/wnl.56.4.548 · Cited by 425
Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease
Moro, E., Scerrati, M., Romito, L. M. A., Roselli, R., Tonali, P., & Albanese, A. (1999) · Neurology · doi:10.1212/wnl.53.1.85 · Cited by 420
Subthalamic DBS replaces levodopa in Parkinson’s disease: Two-year follow-up
Vingerhoets, F. J. G., Villemure, J.-G., Temperli, P., Pollo, C., Pralong, E., & Ghika, J. (2002) · Neurology · doi:10.1212/wnl.58.3.396 · Cited by 314
Isease, S. D., & Roup, S. T. G. (2001) · Cited by 292
Saint-Cyr, J. A., Hoque, T., Pereira, L. C. M., Dostrovsky, J. O., Hutchison, W. D., Mikulis, D. J., Abosch, A., Sime, E., Lang, A. E., & Lozano, A. M. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.97.5.1152 · Cited by 291
Self-citationBejjani, B.-P. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.5.595 · Cited by 281
Trépanier, L. L., Kumar, R., Lozano, A. M., Lang, A. E., & Saint-Cyr, J. A. (2000) · Brain and Cognition · doi:10.1006/brcg.1999.1108 · Cited by 241
Self-citationDujardin, K., Defebvre, L., Krystkowiak, P., Blond, S., & Destée, A. (2001) · Journal of Neurology · doi:10.1007/s004150170139 · Cited by 218
Subthalamic Stimulation in Parkinson Disease: A Multidisciplinary Approach
Houeto, J. L., Damier, P., Bejjani, P. B., Staedler, C., Bonnet, A. M., Arnulf, I., Pidoux, B., Dormont, D., Cornu, P., & Agid, Y. (2000) · Archives of Neurology · doi:10.1001/archneur.57.4.461 · Cited by 204
Levodopa Withdrawal After Bilateral Subthalamic Nucleus Stimulation in Advanced Parkinson Disease
Molinuevo, J. L., Valldeoriola, F., Tolosa, E., Rumià, J., Valls-Solé, J., Roldán, H., & Ferrer, E. (2000) · Archives of Neurology · doi:10.1001/archneur.57.7.983 · Cited by 202
Subthalamic nucleus stimulation in Parkinson's disease
Thobois, S., Mertens, P., Guenot, M., Hermier, M., Mollion, H., Bouvard, M., Chazot, G., Broussolle, E., & Sindou, M. (2002) · Journal of Neurology · doi:10.1007/s004150200059 · Cited by 199
Godinho, F., Thobois, S., Magnin, M., Guenot, M., Polo, G., Benatru, I., Xie, J., Salvetti, A., Garcia-Larrea, L., Broussolle, E., et al. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0222-z · Cited by 176
Krack, P., Limousin, P., Benabid, A., & Pollak, P. (1997) · The Lancet · doi:10.1016/s0140-6736(05)64273-0 · Cited by 165
Long-term follow up of subthalamic nucleus stimulation in Parkinson’s disease
Romito, L. M., Scerrati, M., Contarino, M. F., Bentivoglio, A. R., Tonali, P., & Albanese, A. (2002) · Neurology · doi:10.1212/wnl.58.10.1546 · Cited by 148
Simuni, T., Jaggi, J. L., Mulholland, H., Hurtig, H. I., Colcher, A., Siderowf, A. D., Ravina, B. M., Skolnick, B. E., Goldstein, R., Stern, M. B., et al. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.96.4.0666 · Cited by 143
Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
Rodríguez-Oroz, M. C., Gorospe, A., Guridi, J., Ramos, E., Linazasoro, G., Rodriguez‐Palmero, M., & Obeso, J. A. (2000) · PubMed · Cited by 121
Valldeoriola, F., Pilleri, M., TOLOSA, E. S., Molinuevo, J. L., Rumià, J., & Ferrer, E. (2002) · Movement Disorders · doi:10.1002/mds.1278 · Cited by 104
Hauser, R. A., & Holford, N. H. G. (2002) · Movement Disorders · doi:10.1002/mds.10226 · Cited by 74
Lesion of thalamic centromedian– parafascicular complex after chronic deep brain stimulation
Henderson, J. M., O'Sullivan, D. J., Pell, M. F., Fung, V. S. C., Hely, M. A., Morris, J. G. L., & Halliday, G. M. (2001) · Neurology · doi:10.1212/wnl.56.11.1576 · Cited by 47
Cited by
Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease
Benabid, A. L., Chabardes, S., Mitrofanis, J., & Pollak, P. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70291-6 · Cited by 1,285
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up
Rodriguez-Oroz, M. C., Obeso, J. A., Lang, A. E., Houeto, J.-L., Pollak, P., Rehncrona, S., Kulisevsky, J., Albanese, A., Volkmann, J., Hariz, M. I., et al. (2005) · Brain · doi:10.1093/brain/awh571 · Cited by 1,057
Self-citationSubthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
Kleiner-Fisman, G., Herzog, J., Fisman, D. N., Tamma, F., Lyons, K. E., Pahwa, R., Lang, A. E., & Deuschl, G. (2006) · Movement Disorders · doi:10.1002/mds.20962 · Cited by 957
Self-citationPlaha, P. (2006) · Brain · doi:10.1093/brain/awl127 · Cited by 515
Parsons, T. D., Rogers, S. A., Braaten, A. J., Woods, S. P., & Tröster, A. I. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70475-6 · Cited by 500
Metadata
- Authors
- Kleiner-Fisman, G., Fisman, D. N., Sime, E., Saint-Cyr, J. A., Lozano, A. M., & Lang, A. E.
- Venue
- Journal of Neurosurgery
- Published
- 2003-09
- Volume
- 99
- Issue
- 3
- Pages
- 489-495
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2032376916
- Cited by
- 351
- References
- 29
- FWCI
- 18.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.